关注
Snezana Radivojev
Snezana Radivojev
Head of Pharmaceutical Development, G.ST Antivirals
在 gst-antivirals.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs
S Radivojev, S Zellnitz, A Paudel, E Froehlich
International journal of pharmaceutics 556, 45-56, 2019
582019
Use of PBPK Modeling To Evaluate the Performance of DissolvIt, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products
M Hassoun, M Malmlöf, O Scheibelhofer, A Kumar, S Bansal, E Selg, ...
Molecular pharmaceutics 16 (3), 1245-1254, 2019
292019
Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance
S Radivojev, G Luschin-Ebengreuth, JT Pinto, P Laggner, A Cavecchi, ...
International Journal of Pharmaceutics 606, 120893, 2021
272021
How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation
JT Pinto, S Radivojev, S Zellnitz, E Roblegg, A Paudel
International Journal of Pharmaceutics 528 (1-2), 416-428, 2017
202017
Insights into DPI sensitivity to humidity: An integrated in-vitro-in-silico risk-assessment
S Radivojev, JT Pinto, E Fröhlich, A Paudel
Journal of Drug Delivery Science and Technology 52, 803-817, 2019
92019
Elucidation of the effect of added fines on the performance of dry powder inhalation formulations
M Stankovic-Brandl, S Radivojev, P Sailer, FK Penz, A Paudel
International Journal of Pharmaceutics 629, 122359, 2022
32022
Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug …
S Radivojev, L Kargl, JT Pinto, M Swedrowska, M Malmlöf, C Meindl, ...
International Journal of Pharmaceutics 661, 124455, 2024
2024
The Use of Integrated in-Vitro-in-Silico frameworks Toward De-Risking Low-Dose Dry Powder Inhalation Development
J Pinto, S Radivojev, V Reinisch, E Fröhlich, A Paudel
2022 AIChE Annual Meeting, 2022
2022
Investigation on the impact of resonant acoustic mixing parameters and carrier type on the deposition patterns of Budesonide/Formoterol Fumarate DPI combination product
S Radivojev, M Beretta, V Reinisch, JT Pinto, E Fronich, A Paudel
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A14-A15, 2022
2022
THE RELEVANCE OF SIMULATED LUNG FLUID COMPOSITION ON THE DRUG SOLUBILITY AND PREDICTED IN-VIVO PERFORMANCE OF INHALED DRUG DELIVERY
S Radivojev, G Luschin-Ebengreuth, JT Pinto, A Paudel, E Froehlich
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 34 (3), A11-A11, 2021
2021
Structural investigation into the physical interactions of itraconazole with DPPC
S Radivojev, JT Pinto, P Laggner, E Froehlich, A Paudel
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 33 (2), A6-A7, 2020
2020
Insights into humidity-induced changes on the in-vitro pulmonary deposition and the predicted plasma levels of budesonide from commercial DPIs: a pharmacokinetic model assisted …
S Radivojev, JT Pinto, E Froehlich, A Paudel
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 32 (2), A4-A4, 2019
2019
INSIGHTS INTO DPI SENSITIVITY TO HUMIDITY AND ITS CORRELATION TO FORMULATION PHYSICOCHEMICAL CHARACTERISTICS: A TEMPORAL STUDY USING TWO COMMERCIAL BUDESONIDE PRODUCTS
JT Pinto, S Radivojev, E Froehlich, A Paudel
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 32 (2), A2-A2, 2019
2019
The influence of mucus on the permeability of inhalable APIs
S Radivojev, L Kargl, C Meindl, JT Pinto, A Paudel, E Fröhlich
Session A: Analytics I, 0
系统目前无法执行此操作,请稍后再试。
文章 1–14